Andrew Kenneth William Powell
CIK 1304113 · SVP, General Counsel & Crp Sec · last filed 2024-06-04
Andrew Kenneth William Powell is a SVP, General Counsel & Crp Sec who has filed 58 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for ACRS, was dated Jun 4, 2024. Across all open-market trades the lifetime net is −$203.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $144.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$144.8K
8
58
-$203.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRS | Director | 33,523 | $4.32 | $144.8K | $27.5K | 14 | 2024-06-04 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | — | $5.87 | — | $0 | 3 | 2022-06-13 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 27,477 | $8.76 | $240.7K | $6.1K | 11 | 2022-06-07 |
| Synthorx, Inc. (THOR) Delisted | Director | — | — | — | $0 | 3 | 2020-01-24 |
| MEDIVATION, INC. (MDVN) Delisted | SVP, General Counsel & Crp Sec | 28,517 | — | — | -$155.8K | 5 | 2016-06-06 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | EVP, General Counsel | 89,785 | $1.95 | $175.1K | -$91.4K | 10 | 2013-08-30 |
| IMCLONE SYSTEMS INC (IMCL) Delisted | SVP and General Counsel | — | — | — | $0 | 1 | 2008-08-12 |
| COLLAGENEX PHARMACEUTICALS INC (CGPI) Delisted | VP, G. Counsel and Corp. Sec. | 7,500 | — | — | $10.6K | 5 | 2007-11-30 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-04 | ACRS | Exer (M) | +4,660 | $0 | EDGAR |
| 2024-03-05 | ACRS | Buy (P) | +14,500 | $18.0K | EDGAR |
| 2023-06-05 | ACRS | Mixed | +4,507 | $0 | EDGAR |
| 2023-01-20 | ACRS | Gift (G) | −4,000 | $0 | EDGAR |
| 2022-06-13 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-07 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Mixed | +7,059 | $67.1K | EDGAR |
| 2022-06-06 | ACRS | Mixed | +2,647 | $0 | EDGAR |
| 2022-06-02 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-03 | ACRS | Gift (G) | −5,500 | $0 | EDGAR |
| 2021-09-21 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | — | $0 | EDGAR |